Apremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation

Article

Abstract: Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment o

Palabras claves:

Apremilast, inflammation, Microemulsion, Phosphodiesterase 4, Skin Diseases

Autores:

Badia J., Calpena A.C., Díaz-Garrido N., Fábrega M.J., Halbaut L., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J., Silva-Abreu M.

Fuentes:

scopus